查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600296

通用感染疾病治療市場：按疾病類型、治療方法、給藥途徑和最終用戶分類 - 2025-2030 年全球預測

Zoonotic Disease Treatment Market by Disease Type (Hantavirus, Leishmaniasis, Lyme Disease), Treatment (Antibiotics, Antifungal Medications, Antiparasitic Treatments), Route of Administration, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年通用感染疾病治療市場價值為381.1億美元，預計2024年將達到401.6億美元，複合年成長率為5.45%，2030年將達552.7億美元，預計將達到1000萬美元。

通用感染疾病治療市場包括動物和人類之間傳播的疾病的診斷、預防和治療。隨著人類、動物和生態世界之間的連結不斷增加，新冠肺炎 (COVID-19)、伊波拉出血熱和茲卡等通用感染疾病凸顯了有效管理的必要性。這些治療對於保護公眾健康至關重要，並在醫院、診所和研究機構中得到應用。快速的都市化、國際旅行的增加以及人類與動物接觸的增加正在推動需求，將醫療保健和製藥行業定位為重要的最終用途行業。

主要市場統計
基準年[2023] 381.1億美元
預測年份 [2024] 401.6億美元
預測年份 [2030] 552.7億美元
複合年成長率（%） 5.45%

關鍵的成長要素包括診斷工具的技術進步、政府和非政府資金的增加以及對整合人類、動物和環境健康的跨學科「同一個健康」方法的更多關注。對生物技術和疫苗開發的投資不斷增加，為尋求開拓創新解決方案的市場相關人員提供了潛在機會。解決抗菌素抗藥性並整合人工智慧驅動的預測模型是一個有前途的研究和創新領域，為增強疾病預測和應對策略提供了商業前景。

然而，市場面臨挑戰，包括監管障礙、開發和部署先進治療方法的高成本以及資源匱乏地區監測基礎設施的差距。資料共用和國際政策協調的不一致也可能阻礙有效的全球應對措施的協調。為了緩解這些限制，我們建議促進官民合作關係，加強跨部門合作，並倡導建立更強大的全球衛生框架。

畢竟，隨著新興感染疾病威脅的增加，保護公眾健康的迫切需求動態地驅動著市場動態。企業應專注於全面的監測系統、創新的疫苗平台和擴充性的治療解決方案，以及靈活的供應鏈和區域性的生產能力。透過利用基因組學和生物資訊學的進步，公司可以適應這個複雜且不斷變化的環境並取得成功。

市場動態：快速發展的通用感染疾病治療市場的關鍵市場洞察

通用感染疾病治療市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 政府針對通用感染疾病的措施和政策
    • 全球通用感染疾病增加
    • 擴大抗病毒藥物和疫苗
  • 市場限制因素
    • 缺乏對通用感染疾病的認知與教育
  • 市場機會
    • 擴大獸醫服務和動物保健以預防通用感染疾病
    • 加大生物技術投入，加速先進療法研發
  • 市場挑戰
    • 通用感染疾病治療的複雜監管要求

波特的五力：駕馭通用感染疾病治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解通用感染疾病治療市場的外在影響

外部宏觀環境因素在塑造通用感染疾病治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解通用感染疾病治療市場的競爭狀況

對通用感染疾病治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV通用感染疾病市場供應商的定位矩陣績效評估

FPNV定位矩陣是評估通用感染疾病治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，以規劃通用感染疾病治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對通用感染疾病治療市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 政府應對通用感染疾病的措施和政策
      • 全球通用感染疾病的發生率正在上升
      • 增加抗病毒藥物和疫苗的使用
    • 抑制因素
      • 缺乏對通用感染疾病的認知與教育
    • 機會
      • 擴大獸醫服務和動物保健以預防通用感染疾病
      • 生物技術投資的增加推動先進治療方法的發展
    • 任務
      • 通用感染疾病治療的複雜監管要求
  • 市場區隔分析
    • 治療：由於急性細菌感染疾病增加，對抗生素的需求增加
    • 最終使用者：獸醫醫院的快速擴張，用於治療多種通用感染疾病
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章通用感染疾病治療市場：依疾病類型

  • 漢他病毒屬
  • 利什曼原蟲症
  • 萊姆病
  • 狂犬病
  • 癬
  • 弓漿蟲病
  • 結核
  • 兔熱病
  • 病毒性肝炎

第7章通用感染疾病治療市場（依治療分類）

  • 抗生素
  • 抗真菌藥物
  • 驅蟲治療
  • 抗病毒藥物
  • 疫苗

第8章通用感染疾病治療市場：依給藥途徑分類

  • 可注射的
  • 口服
  • 話題

第9章通用感染疾病治療市場：依最終使用者分類

  • 家庭保健
  • 獸醫診所
  • 動物醫院

第10章 北美和南美通用感染疾病治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太通用感染疾病治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲通用感染疾病治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 華盛頓州立大學獲得 150 萬美元津貼，用於防止動物間病毒在牲畜中傳播
    • 雷迪博士實驗室在美國推出廣效抗生素來對抗細菌感染疾病
  • 戰略分析和建議

公司名單

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cadila Pharmaceuticals Limited
  • CSC Pharmaceuticals International
  • CSL Limited
  • CureVac NV
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Emergent BioSolutions Inc.
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • GSK PLC
  • Johnson & Johnson Services, Inc.
  • Kamada Ltd.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi SA
  • Sinovac Biotech Ltd.
  • Taj Pharmaceuticals Limited
  • Takeda Pharmaceutical Company Limited
  • Vaxart, Inc.
Product Code: MRR-0315DDADCE31

The Zoonotic Disease Treatment Market was valued at USD 38.11 billion in 2023, expected to reach USD 40.16 billion in 2024, and is projected to grow at a CAGR of 5.45%, to USD 55.27 billion by 2030.

The zoonotic disease treatment market involves the diagnosis, prevention, and treatment of diseases transmitted between animals and humans. As the global interface between humans, animals, and ecosystems continues to increase, zoonotic diseases such as COVID-19, Ebola, and Zika highlight the necessity for effective management. These treatments are pivotal in safeguarding public health, with applications spanning hospitals, clinics, and research institutions. Rapid urbanization, the rise of international travel, and expanding human-animal contact drive demand, positioning the healthcare and pharmaceutical industries as crucial end-use sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 38.11 billion
Estimated Year [2024] USD 40.16 billion
Forecast Year [2030] USD 55.27 billion
CAGR (%) 5.45%

Key growth factors include technological advancements in diagnostic tools, increased governmental and non-governmental funding, and a rising focus on interdisciplinary 'One Health' approaches that integrate human, animal, and environmental health. The expanding investment in biotechnology and vaccine development presents potential opportunities for market players aiming to pioneer innovative solutions. Addressing antimicrobial resistance and integrating AI-driven predictive modeling represent promising areas for research and innovation, offering prospects for businesses to enhance disease forecasting and response strategies.

However, the market faces challenges, such as regulatory hurdles, the high cost of developing and deploying advanced treatments, and gaps in surveillance infrastructures in low-resource settings. Inconsistencies in data sharing and international policy alignment can also hinder effective global response coordination. As such, fostering public-private partnerships, enhancing cross-sector collaborations, and advocating for strengthened global health frameworks are recommended to mitigate these constraints.

Ultimately, the zoonotic disease treatment market is dynamic, driven by the urgent need to protect public health amid the growing threat of emerging infectious diseases. Companies should focus on comprehensive surveillance systems, innovative vaccine platforms, and scalable therapeutic solutions, emphasizing agile supply chains and localized production capacities to effectively address regional demands. In leveraging advancements in genomics and bioinformatics, businesses can better adapt and thrive in this intricate, evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Zoonotic Disease Treatment Market

The Zoonotic Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and policies addressing zoonotic diseases
    • Rising incidences of zoonotic diseases globally
    • Increasing prevalence of antiviral drugs and vaccines
  • Market Restraints
    • Limited awareness and education about zoonotic diseases
  • Market Opportunities
    • Expansion of veterinary services and animal healthcare for zoonotic disease prevention
    • Rising investment in biotechnology fostering development of advanced treatments
  • Market Challenges
    • Complex regulatory requirements for zoonotic disease treatments

Porter's Five Forces: A Strategic Tool for Navigating the Zoonotic Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Zoonotic Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Zoonotic Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Zoonotic Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Zoonotic Disease Treatment Market

A detailed market share analysis in the Zoonotic Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Zoonotic Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Zoonotic Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Zoonotic Disease Treatment Market

A strategic analysis of the Zoonotic Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Zoonotic Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bavarian Nordic A/S, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Cadila Pharmaceuticals Limited, CSC Pharmaceuticals International, CSL Limited, CureVac N.V., Dr. Reddy's Laboratories, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Genentech, Inc., Gilead Sciences, Inc., GSK PLC, Johnson & Johnson Services, Inc., Kamada Ltd., Merck & Co., Inc., Moderna, Inc., Mylan N.V., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Sinovac Biotech Ltd., Taj Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited, and Vaxart, Inc..

Market Segmentation & Coverage

This research report categorizes the Zoonotic Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Hantavirus, Leishmaniasis, Lyme Disease, Rabies, Ringworm, Toxoplasmosis, Tuberculosis, Tularemia, and Viral Hepatitis.
  • Based on Treatment, market is studied across Antibiotics, Antifungal Medications, Antiparasitic Treatments, Antiviral Medications, and Vaccines.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on End-User, market is studied across Home Healthcare, Veterinary Clinics, and Veterinary Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and policies addressing zoonotic diseases
      • 5.1.1.2. Rising incidences of zoonotic diseases globally
      • 5.1.1.3. Increasing prevalence of antiviral drugs and vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and education about zoonotic diseases
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of veterinary services and animal healthcare for zoonotic disease prevention
      • 5.1.3.2. Rising investment in biotechnology fostering development of advanced treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory requirements for zoonotic disease treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Increased demand for antibiotics with rise in acute bacterial infections
    • 5.2.2. End-User: Rapid expansion of veterinary hospitals for treating extensive zoonotic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Zoonotic Disease Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Hantavirus
  • 6.3. Leishmaniasis
  • 6.4. Lyme Disease
  • 6.5. Rabies
  • 6.6. Ringworm
  • 6.7. Toxoplasmosis
  • 6.8. Tuberculosis
  • 6.9. Tularemia
  • 6.10. Viral Hepatitis

7. Zoonotic Disease Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Antifungal Medications
  • 7.4. Antiparasitic Treatments
  • 7.5. Antiviral Medications
  • 7.6. Vaccines

8. Zoonotic Disease Treatment Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Zoonotic Disease Treatment Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Healthcare
  • 9.3. Veterinary Clinics
  • 9.4. Veterinary Hospitals

10. Americas Zoonotic Disease Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Zoonotic Disease Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Zoonotic Disease Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. WSU Secures USD 1.5M Grant to Combat Animal-to-Human Virus Spread in Livestock
    • 13.3.2. Dr. Reddy's Laboratories Launches Broad-Spectrum Antibiotics in the U.S. to Tackle Bacterial Infections
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Bavarian Nordic A/S
  • 3. Bayer AG
  • 4. Boehringer Ingelheim GmbH
  • 5. Bristol-Myers Squibb Company
  • 6. Cadila Pharmaceuticals Limited
  • 7. CSC Pharmaceuticals International
  • 8. CSL Limited
  • 9. CureVac N.V.
  • 10. Dr. Reddy's Laboratories
  • 11. Eli Lilly and Company
  • 12. Emergent BioSolutions Inc.
  • 13. F. Hoffmann-La Roche AG
  • 14. Genentech, Inc.
  • 15. Gilead Sciences, Inc.
  • 16. GSK PLC
  • 17. Johnson & Johnson Services, Inc.
  • 18. Kamada Ltd.
  • 19. Merck & Co., Inc.
  • 20. Moderna, Inc.
  • 21. Mylan N.V.
  • 22. Novartis AG
  • 23. Pfizer Inc.
  • 24. Regeneron Pharmaceuticals, Inc.
  • 25. Sanofi S.A.
  • 26. Sinovac Biotech Ltd.
  • 27. Taj Pharmaceuticals Limited
  • 28. Takeda Pharmaceutical Company Limited
  • 29. Vaxart, Inc.

LIST OF FIGURES

  • FIGURE 1. ZOONOTIC DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ZOONOTIC DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ZOONOTIC DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ZOONOTIC DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ZOONOTIC DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ZOONOTIC DISEASE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY HANTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RINGWORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TOXOPLASMOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TULAREMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIFUNGAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIPARASITIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIVIRAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. ZOONOTIC DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 200. ZOONOTIC DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023